Indefinite Delivery Contract 75F40120D00005

Award Date 2/11/20
Last Date to Order 2/10/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a single-award, indefinite delivery contract to Dun & Bradstreet Inc., a leading global provider of business decisioning data and analytics. The 5-year, $46 million contract provides access to Dun & Bradstreet's commercial data, analytics, and business information services to support the FDA's regulatory and compliance objectives. Task orders issued under this contract include database...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) valued at $45 million to Iqvia Government Solutions Inc., a leading provider of healthcare data, analytics, and related services to federal agencies. The contract enables the FDA to issue task orders for access to outpatient prescription and patient-level drug utilization data to support its regulatory programs and post-market drug safety monitoring initiatives over a...
The Department of Health and Human Services Food and Drug Administration awarded Deloitte Consulting LLP a blanket purchase agreement with a potential value of $90 million to provide scientific services under ordering agreement EO14042. Deloitte received multiple task orders against this vehicle from 2022 through 2026 to support various FDA programs. Services include regulatory analytics and assessment, data management, knowledge management capabilities development, workflow harmonization and...
The Federal Contract IDV award is a single-award Indefinite Delivery Contract valued at up to $3,446,837.42 for a period of performance from May 16, 2023 to May 16, 2026. The contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Syneos Health Research & Insights LLC. The contract aims to provide the FDA with access to healthcare practitioner prescribing practices data. The original solicitation was a combined synopsis/solicitation for commercial items,...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to Iqvia Government Solutions Inc., a for-profit organization specializing in healthcare data, analytics, and research services. The contract has a ceiling value of $4,463,492.67 and a period of performance extending to July 14, 2030. The primary objective of this contract is to provide the FDA with comprehensive hospital inpatient and emergency department drug...
This Blanket Purchase Agreement (BPA) contract, awarded by the Food and Drug Administration (FDA), has a total ceiling value of $500,000,000 and a period of performance through August 26, 2029. The contract was awarded to Deloitte Consulting LLP, a large for-profit management and technology consulting firm, to provide a broad range of services focused on modernizing the FDA's data and analytics capabilities. The contract is structured as a multiple award BPA, allowing the FDA to issue task...
The Food and Drug Administration (FDA), a civilian agency, has awarded a $35 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Data Quality Science, LLC, a small business based in Catonsville, Maryland. The IDIQ contract is for tobacco retailer inspection services in FDA Region 4, which covers several western U.S. states and territories. Under this IDIQ, the FDA has issued multiple delivery orders to Data Quality Science to conduct various types of inspections, including...
This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Iqvia Government Solutions Inc., a for-profit provider of advanced analytics, technology solutions, and clinical research services. The contract, valued at up to $2,397,717.80, is for ACCESS TO HOSPITAL INPATIENT AND EMERGENCY DEPARTMENT DRUG UTILIZATION DATA. This single-award IDC, which does not include any set-asides,...
This Indefinite Delivery Contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to Circana, LLC (doing business as Infoscan), a for-profit data and analytics firm. The single-award $20,001,000.00 Indefinite Delivery Indefinite Quantity (IDIQ) contract runs from April 2, 2024 through April 1, 2029 and serves as a comprehensive vehicle for the FDA and potentially other federal partners to access Circana's consumer insights, data, and analytics services through...
The Food and Drug Administration (FDA), a civilian federal agency, awarded a single-award Indefinite Delivery Contract (IDC) worth up to $103 million to Pn-Heitech, LLC, a minority-owned small business. The contract aims to procure a range of information technology, medical device regulatory, and records modernization services to support the agency's mission. Under this IDC, the FDA has issued multiple firm fixed-price, labor hour, and time-and-materials delivery orders for services such as help...
  • 75F40120D00005
    Indefinite Delivery Contract
  • 24
    Federal Contract Awards

The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $60 million Indefinite Delivery, Indefinite Quantity (IDIQ) contract to Dun & Bradstreet Inc., doing business as Dun & Bradstreet Receivable Management Services, for database subscriptions, analytical services, and licensing. Under this contract, Dun & Bradstreet will provide the FDA with access to its commercial data and analytics to support the agency's regulatory, compliance, and enforcement programs. Delivery orders issued under this IDIQ include subscriptions to Dun & Bradstreet's databases and platforms, as well as professional services such as counterfactual analysis, data integrations, and core IT support. The contract has a period of performance through February 2025 and does not include any set-aside designations. Dun & Bradstreet is a leading global provider of business decisioning data and analytics that supports numerous federal agencies across civilian and defense sectors through similar indefinite delivery vehicles.

The FDA has also issued several individual delivery orders to Dun & Bradstreet under this IDIQ, valued at up to $28.8 million, for database subscriptions, core data services, and analytical support. These firm fixed price delivery orders enable the FDA to access Dun & Bradstreet's business information and insights to advance its public health mission, such as by monitoring small business resiliency and supporting regulatory oversight of medical products. The contract work will primarily be performed at Dun & Bradstreet's locations in Virginia and Maryland.

Generated 7/9/24, 1:33 PM